Skip to Content

M O17 (Oxybutynin Chloride Extended Release 15 mg)

Pill with imprint M O17 is Gray, Round and has been identified as Oxybutynin Chloride Extended Release 15 mg. It is supplied by Mylan Pharmaceuticals Inc..

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis (and more), and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M O17

Oxybutynin chloride extended release 15 mg M O17
Oxybutynin chloride extended release 15 mg M O17  Front
Oxybutynin chloride extended release 15 mg M O17  Back
Oxybutynin chloride extended release 15 mg M O17

Oxybutynin Chloride Extended Release

Imprint:
M O17
Strength:
15 mg
Color:
Gray
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54868-5743 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide